2021 annual financial data
BridgeBio Pharma 2021 Operating cash flow margin
BridgeBio Pharma 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -714.23%.
Operating income was -576,632,000 USD and net income was -562,539,000 USD.
Operating cash flow was -497,934,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 69,716,000 USD
- Operating income
- -576,632,000 USD
- Net income
- -562,539,000 USD
- Operating cash flow
- -497,934,000 USD